A model for antigen-specific T-cell anergy:: Displacement of CD4-p56lck signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera

被引:26
作者
Thomas, S [1 ]
Kumar, R [1 ]
Preda-Pais, A [1 ]
Casares, S [1 ]
Brumeanu, TD [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA
关键词
D O I
10.4049/jimmunol.170.12.5981
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Soluble, dimeric peptide-MHC chimeras were shown to induce Ag-specific T cell anergy in vitro and in vivo. In this study, we describe a mechanism by which a soluble, dimeric peptide MHC class II chimera (DEF) induces Ag-specific T cell anergy. The anergic cells showed a displacement of the CD4-p56(lck) signaling module from the GM1-rich plasma membrane microdomains (lipid rafts), and subsequently an increase in p59(fyn) kinase activity, a dominant expression of p21 inhibitory TCR zeta-chain, and a poor phosphorylation and recruitment of zeta-associated protein of 70 kDa kinase to the TCR's immunoreceptor tyrosine-based activation motifs. The Th1 and Th2 transcription was suppressed and the cells were arrested in the Th0 stage of differentiation. Recovery from DEF anergy occurred late and spontaneously at the expense of low thresholds for activation-induced cell death. In contrast to DEF, a combination of TCR and CD4 mAbs did not induce such alterations or anergy, indicating that the ligand-mediated topology of TCR and CD4 coengagement can differentially affect the T cell function. Our results argue for a model of anergy in which the defective partitioning of signaling molecules in lipid rafts is an early, negative signaling event in T cells. Physiological ligands like DEF chimeras may provide new tools for silencing the autoimmune processes, and may also help in deciphering new mechanisms of negative regulation in T cells.
引用
收藏
页码:5981 / 5992
页数:12
相关论文
共 72 条
[1]   Successive expression and activation of NFAT family members during thymocyte differentiation [J].
Adachi, S ;
Amasaki, Y ;
Miyatake, S ;
Arai, N ;
Iwata, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (19) :14708-14716
[2]  
ALLAND L, 1994, J BIOL CHEM, V269, P16701
[3]   Anergy induction by dimeric TCR ligands [J].
Appel, H ;
Seth, NP ;
Gauthier, L ;
Wucherpfennig, KW .
JOURNAL OF IMMUNOLOGY, 2001, 166 (08) :5279-5285
[4]   THE HUMAN P50(CSK) TYROSINE KINASE PHOSPHORYLATES P56(LCK) AT TYR-505 AND DOWN REGULATES ITS CATALYTIC ACTIVITY [J].
BERGMAN, M ;
MUSTELIN, T ;
OETKEN, C ;
PARTANEN, J ;
FLINT, NA ;
AMREIN, KE ;
AUTERO, M ;
BURN, P ;
ALITALO, K .
EMBO JOURNAL, 1992, 11 (08) :2919-2924
[5]  
BERNADETTA MM, 1998, BLOOD, V91, P3390
[6]   BLOCKADE OF THE CD28 COSTIMULATORY PATHWAY - A MEANS TO INDUCE TOLERANCE [J].
BOUSSIOTIS, VA ;
GRIBBEN, JG ;
FREEMAN, GJ ;
NADLER, LM .
CURRENT OPINION IN IMMUNOLOGY, 1994, 6 (05) :797-807
[7]   Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1 [J].
Boussiotis, VA ;
Freeman, GJ ;
Berezovskaya, A ;
Barber, DL ;
Nadler, LM .
SCIENCE, 1997, 278 (5335) :124-128
[8]  
Brumeanu T D, 2001, Int Rev Immunol, V20, P301, DOI 10.3109/08830180109043041
[9]   Engineering and characterization of a murine MHC class II-immunoglobulin chimera expressing an immunodominant CD4 T viral epitope [J].
Casares, S ;
Bona, CA ;
Brumeanu, TD .
PROTEIN ENGINEERING, 1997, 10 (11) :1295-1301
[10]   Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide MHC class II chimera [J].
Casares, S ;
Hurtado, A ;
McEvoy, RC ;
Sarukhan, A ;
von Boehmer, H ;
Brumeanu, TD .
NATURE IMMUNOLOGY, 2002, 3 (04) :383-391